[1]Muncie HL Jr, Campbell J. Alpha and beta thalassemia. Am Fam Physician. 2009 Aug 15;80(4):339-44. [2]Harteveld CL, Higgs DR. Alpha-thalassaemia. Orphanet J Rare Dis. 2010 May 28;5:13. [3]Xian J, Wang Y, He J, et al. Molecular Epidemiology and Hematologic Characterization of Thalassemia in Guangdong Province, Southern China. Clin Appl Thromb Hemost. 2022 .Jan-Dec;28:10760296221119807. [4]Cheng Y, Chen M, Ye J, et al. The prevalence and outcomes of α- and β-thalassemia among pregnant women in Hubei Province, Central China: An observational study. Medicine (Baltimore). 2022 Mar 4;101(9):e28790. [5]roğlu AG, Uluğ N, Karakaş H, et al. Evaluation of left ventricular function and myocardial deformation in children with beta-thalassemia major by real-time threedimensional (four-dimensional) and speckle tracking echocardiography. Echocardiography. 2022 Oct;39(10):1307-1315. [6]Aessopos A, Kati M, Farmakis D. Heart disease in thalassemia intermedia: a review of the underlying pathophysiology. Haematologica. 2007 May;92(5):658-65. [7]Chang CH, Chang FM, Yu CH, Liang RI, Ko HC, Chen HY. Systemic assessment of fetal hemodynamics by Doppler ultrasound. Ultrasound Med Biol. 2000 Jun;26(5):777-85. [8]Abuhamad A. Color and pulsed Doppler in fetal echocardiography. Ultrasound Obstet Gynecol. 2004 Jul;24(1):1-9. [9]Veille JC, Hanson R, Steele L, Tatum K. M-mode echocardiographic evaluation of fetal and infant hearts: longitudinal follow-up study from intrauterine life to year one. Am J Obstet Gynecol. 1996 Oct;175(4 Pt 1):922-8. [10]Li H, Wang J, Wang D, et al Ten years’ experience in prenatal diagnosis of α-thalassemia in a municipal hospital and retrospective analysis of ultrasonic abnormalities. Int J Hematol. 2023 Sep;118(3):355-363. [11]Vlachodimitropoulou E, Mogharbel H, Kuo KHM, et al. Pregnancy outcomes and iron status in β-thalassemia major and intermedia: a systematic review and metaanalysis. Blood Adv. 2024 Feb 13;8(3):746-757. [12]李莉艳,王志坚.妊娠期地中海贫血的管理与遗传咨询[J].中国实用妇科与产科杂志,2022,38(12):1159-1163. [13]Baird DC, Batten SH, Sparks SK. Alpha- and Beta-thalassemia: Rapid Evidence Review. Am Fam Physician. 2022 Mar 1;105(3):272-280. [14]Harn-A-Morn P, Wanapirak C, Sirichotiyakul S,et al. Effectiveness of ultrasound algorithm in prenatal diagnosis of hemoglobin Bart’s disease among pregnancies at risk. Int J Gynaecol Obstet. 2022 Nov;159(2):451-456. [15]Chankhunaphas W, Tongsong T, Tongprasert F, et al. Comparison of the Performances of Middle Cerebral Artery Peak Systolic Velocity and Cardiothoracic Diameter Ratio in Predicting Fetal Anemia: Using Fetal Hemoglobin Bart’s Disease as a Study Model. Fetal Diagn Ther. 2021;48(10):738-745. [16]丁丽娜,袁婷婷,李少英,等.产前超声检查在Hb Bart′s胎儿水肿综合征中的预测价值[J].实用妇产科杂志,2019,35(12):928-932. [17]Li X, Qiu X, Huang H, et al. Fetal heart size measurements as new predictors of homozygous α-thalassemia-1 in mid-pregnancy. Congenit Heart Dis. 2018 Mar;13(2):282-287. [18]Nattawongsiri C, Tongprasert F, Tongsong T. Fetal Heart Diameter as a Predictor of Hemoglobin Bart Disease at Midpregnancy. J Ultrasound Med. 2021 Mar;40(3):553-557. [19]Thammavong K, Luewan S, Tongsong T. Performance of Fetal Cardiac Volume Derived from VOCAL (Virtual Organ Computer-Aided AnaLysis) in Predicting Hemoglobin (Hb) Bart’s Disease. J Clin Med. 2021 Oct 11;10(20):4651. [20]Tongprasert F, Srisupundit K, Luewan S, et al. The best cutoff value of middle cerebral artery peak systolic velocity for the diagnosis of fetal homozygous alpha thalassemia-1 disease. Prenat Diagn. 2019 Feb;39(3):232-237. [21]Anuwutnavin S, Rangseechamrat P, Sompagdee N, et al. Comparing three cardiothoracic ratio measurement techniques and creating multivariable scoring system to predict Bart’s hydrops fetalis at 17-22 weeks’ gestation. Sci Rep. 2024 Apr 17;14(1):8894. [22]葛群.超声检测静脉导管血流频谱变化在水肿胎的研究[D].广州医学院,2011. [23]Jatavan P, Sekararithi R, Jaiwongkam T, et al. Comparisons of serum non-transferrin-bound iron levels and fetal cardiac function between fetuses affected with hemoglobin Bart’s disease and normal fetuses. Front Med (Lausanne). 2023 Jan 3;9:1015306 [24]谢许萍,程志坚,罗葆明,等.超声检测右室Tei指数对重型α-地中海贫血的诊断价值研究[J].广西医科大学学报,2019,36(05):812-815. [25]覃翠优,马燕,金彬彬,等.心肌做功指数、心胸比率、大脑中动脉峰值流速评估胎儿重型α地中海贫血风险的价值[J].中国医学影像学杂志,2021,29(09):909-913. [26]Tongprasert F, Srisupundit K, Luewan S, et al. Fetal isovolumetric time intervals as a marker of abnormal cardiac function in fetal anemia from homozygous alpha thalassemia-1 disease. Prenat Diagn. 2017 Oct;37(10):1028-1032. [27]Peixoto AB, Bravo-Valenzuela NJ, Rocha LA, et al. Spectral Doppler, tissue Doppler, and speckle-tracking echocardiography for the evaluation of fetal cardiac function: an update. Radiol Bras. 2021 Mar-Apr;54(2):99-106. [28]卢菁菁,何立红,乔丽,等.组织多普勒超声评价地中海贫血胎儿的心脏纵向功能[J].吉林医学,2016,37(04):803-805. [29]Abuhamad A. Color and pulsed Doppler in fetal echocardiography. Ultrasound Obstet Gynecol. 2004 Jul;24(1):1-9. [30]Anuwutnavin S, Russameecharoen K, Ruangvutilert P, et al. Evaluation of cardiac findings using speckle tracking in fetuses with hemoglobin Bart’s disease. Ultrasound Obstet Gynecol. 2024 May 6. [31]Patsourakos D, Aggeli C, Dimitroglou Y, et al. Speckle tracking echocardiography and β-thalassemia major. A systematic review. Ann Hematol. 2024 Sep;103(9):3335-3356. [32]Luewan S, Apaijai N, Chattipakorn N, et al. Fetal anemia causes placental and maternal cellular damage: a lesson from fetal hemoglobin Bart’s disease. Placenta. 2024 Apr;149:72-77. [33]周春桥,黎新艳,庞彩英,等.中孕期胎盘厚度Z-评分对重型α-地中海贫血的预测价值[J].中国医学影像学杂志,2021,29(03):260-263. [34]Zhang L, Fan E, Chen X, et al. Effects of thalassemia minor on umbilical artery blood flow and perinatal outcomes in pregnancy: A retrospective cohort study. Int J Gynaecol Obstet. 2024 Jul 27. [35]刘利娜,佘玲娜,曾梅,等.超声技术在地中海贫血胎儿产前诊断应用价值分析[J].数理医药学杂志,2019,32(07):1004-1005.